Norsad Capital has provided a R100-million (US$5.4-million) debt funding instrument to RH Bophelo to assist with the group’s expansion of its hospital portfolio in South Africa. RH Bophelo is a healthcare investor that is listed on the Johannesburg Stock Exchange with funds in excess of R500-million. The company invests in hospitals where it can improve facilities and increase access to quality healthcare services to the lower-to-middle income bracket in South Africa. The group also includes the Razorite Healthcare Africa Fund which is registered in Mauritius.
Norsad Capital is an impact investor that provides direct debt financing of between US$5 million to US$10 million to mid-market companies for growth and development. The firm is a long-term funding partner with a typical investment duration of 4 to 7 years on tailor-made financing solutions that enable companies to achieve their strategic goals.